Back to Search
PATRICK LOEHRER, MD
MD
Hematology & Oncology Physician
NPI: 1245296847IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
01030846A(IN)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
01030846(IN)01030846A(IN)
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
01030846A(IN)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1978
Research & Publications (20)
A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.
PMID 17375339·Support Care Cancer·2007
3-trial
Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.
PMID 14722038·J Clin Oncol·2004
3-trial
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
PMID 11391579·Cancer·2001
3-trial
Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease.
PMID 19427738·Int J Radiat Oncol Biol Phys·2010
8-other
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
PMID 19103723·J Clin Oncol·2009
8-other
Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review.
PMID 19494727·J Clin Neuromuscul Dis·2009
5-case
A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma.
PMID 17661038·Cancer Chemother Pharmacol·2008
3-trial
A randomized trial of two print interventions to increase colon cancer screening among first-degree relatives.
PMID 18308500·Patient Educ Couns·2008
4-observational
Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial.
PMID 18391600·Am J Clin Oncol·2008
3-trial
A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker.
PMID 17159154·Proc Natl Acad Sci U S A·2006
4-observational
Locally advanced pancreatic cancer: current therapeutic approach.
PMID 16794240·Oncologist·2006
6-review
A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer.
PMID 16088234·Oncology·2005
3-trial
Do benefits and barriers differ by stage of adoption for colorectal cancer screening?
PMID 15314036·Health Educ Res·2005
8-other
A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study.
PMID 15700131·Support Care Cancer·2005
3-trial
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation.
PMID 15928669·Br J Cancer·2005
8-other
A phase I study of docetaxel, Cisplatin, 5-Fluorouracil and leucovorin.
PMID 16020978·Oncology·2005
3-trial
A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study.
PMID 15493359·Cancer Invest·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 535 BARNHILL DR, RT 448
INDIANAPOLIS, IN 46202 - Phone
- (317) 278-7418
Quick Facts
- NPI
- 1245296847
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 48
- Publications
- 20
Are you this provider?
Claim Your Profile